David Michael Clark - Jan 2, 2023 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role
Chief People Officer
Signature
/s/ Christian Formica, Attorney-in-Fact
Stock symbol
FOLD
Transactions as of
Jan 2, 2023
Transactions value $
-$309,902
Form type
4
Date filed
1/4/2023, 06:21 PM
Previous filing
Oct 11, 2022
Next filing
Jan 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Tax liability -$138K -11.3K -5.4% $12.21 199K Jan 2, 2023 Direct
transaction FOLD Common Stock Sale -$102K -8.49K -4.27% $12.03 190K Jan 3, 2023 Direct F1, F2
transaction FOLD Common Stock Award $0 +59.4K +31.22% $0.00 250K Jan 3, 2023 Direct F3
transaction FOLD Common Stock Tax liability -$69.3K -5.81K -2.33% $11.93 244K Jan 3, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FOLD Stock Options (right to buy) Award $0 +105K $0.00 105K Jan 3, 2023 Common Stock 105K $11.93 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale of common stock was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.82 to $12.24. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in four equal annual installments beginning on January 3, 2024 and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
F4 These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.